Intrinsic Health Partners

Nalu Bio is a biotech company focused on creating cannabinoids through innovative chemical processes rather than traditional plant extraction. This novel approach allows Nalu Bio to produce pure and safe ingredients that are environmentally sustainable, utilizing significantly less land, water, and energy compared to conventional methods. The company's proprietary chemistry platform ensures consistency and quality by generating identical batches of cannabinoids, free from contaminants such as pesticides and THC. Targeting both consumer and pharmaceutical markets, Nalu Bio aims to disrupt the cannabinoid industry by providing a reliable source of high-quality ingredients that meet the growing demand for safe and effective products.

QNTM Labs operates as an analytical laboratory center that specializes in providing research, development, and regulatory compliance services for pharmaceutical companies. The organization focuses on enhancing transparency and access to rigorous scientific analysis by collaborating with global researchers, API manufacturers, and various stakeholders within the pharmaceutical sector. Their services include analytical testing, quality control testing, and support for clinical trials. Additionally, QNTM Labs emphasizes responsible and informed development within the cannabis industry, facilitating the pharmaceutical sector's access to innovative health drugs aimed at improving public health outcomes.

Biopharmaceutical Research Company specializes in the development of active pharmaceutical ingredients specifically for plant-based therapeutics, with a strong emphasis on cannabis and hemp. The company provides comprehensive testing services, including potency and contaminant analysis, and generates stability data, which support researchers in their pursuit of effective treatments for conditions such as post-traumatic stress disorder and chronic pain. By adhering to USDA compliance in THC testing, Biopharmaceutical Research Company ensures that its services meet regulatory standards, aiding researchers throughout the United States in advancing their studies and therapeutic options for patients and veterans.

Hound Labs, Inc. is a company based in Oakland, California, that specializes in developing advanced breath testing technologies to address public health and safety concerns. Founded in 2014, the company’s flagship product, the HOUND® CANNABIS BREATHALYZER, offers a novel approach to cannabis detection by measuring active tetrahydrocannabinol (THC) levels in breath, providing the shortest detection window in the industry. This technology enables employers to objectively test for recent cannabis use, supporting workplace policies that prohibit use during work hours without penalizing employees for consumption outside of work. Hound Labs aims to balance workplace safety and employee privacy in an evolving landscape of cannabis legalization. The company has received funding from various investors, including Benchmark and Tuatara Capital, to advance its innovative solutions.

Treez, Inc. is a software company that develops a retail management platform specifically for the cannabis industry in the United States. Founded in 2016 and based in Oakland, California, Treez offers an enterprise-grade, cloud-based solution that streamlines retail and supply chain operations for medical marijuana dispensaries. Its platform includes essential features such as point of sale, inventory management, and omnichannel sales capabilities, all designed to ensure regulatory compliance throughout the supply chain. Additionally, Treez connects brands with retailers through a centralized catalog and provides real-time market insights. The platform's open API allows for seamless integration with various third-party solutions, enhancing operational efficiency and enabling retailers to adapt to industry changes while maximizing customer value and expanding market presence.

Hound Labs, Inc. is a company based in Oakland, California, that specializes in developing advanced breath testing technologies to address public health and safety concerns. Founded in 2014, the company’s flagship product, the HOUND® CANNABIS BREATHALYZER, offers a novel approach to cannabis detection by measuring active tetrahydrocannabinol (THC) levels in breath, providing the shortest detection window in the industry. This technology enables employers to objectively test for recent cannabis use, supporting workplace policies that prohibit use during work hours without penalizing employees for consumption outside of work. Hound Labs aims to balance workplace safety and employee privacy in an evolving landscape of cannabis legalization. The company has received funding from various investors, including Benchmark and Tuatara Capital, to advance its innovative solutions.